SGLT-2 inhibitors and the metabolic fulcrum

Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 8

Abstract

Treatment potential of sodium glucose transporter-2 (SGLT-2) inhibitors in diabetes was first reported more than two decades ago, but their recently testified effect on reduction of major cardiovascular endpoints in outcome trials has led to renewed enthusiasm in them. Their role in the management of type 2 diabetes assumes more significance given that it is known that kidneys are not just innocent bystanders in this chronic disease, but are also involved in its pathogenesis. Pragmatic useof SGLT-2 inhibitors entails classifying patients based on their metabolic state- the so called metabolic fulcrum. When used in carefully selected patients, these drugs not only help in glycemia control, but also have a variety of favourable effects, like reduction of blood pressure and cardiovascular mortality, and improvement in clinical renal endpoints. In this mini review, we briefly describe the rationale of use of SGLT-2 inhibitors, their effects, usage and major side effects.

Authors and Affiliations

Ashish Sehgal

Keywords

Related Articles

A case of early morning abnormal behavior and refractory epilepsy

Insulinomas are rare neuroendocrine tumors of pancreatic islet cells that retain the ability to produce and secrete inappropriately high insulin. The clinical symptoms of insulinoma are the subsequent to development of h...

Late Onset Headache

Late onset headache presents a challenging problem in neurological practice. New onset headache in persons over 50 is a red flag and secondary causes, some of which may be sinister and life threatening must be ruled out....

Assessing the preparedness and strategies in the management of Dengue disaster in the hospitals

Dengue is fast emerging viral pandemic and incidence has increased over 30-fold the last 50 years. Severe manifestations of dengue outbreaks have always created panic and public have always expected urgent action from he...

Topical heparin for infusion associated superficial thrombophlebitis : A preventive approach

Maintaining a single indwelling intravenour (IV) catheter for a long duration is limited mainly due to the development of superficial thrombophlebitis. This, we decided to evaluate the efficacy and safety of heparin sodi...

Prevalence of obesity, prediabetes, diabetes mellitus, prehypertension and hypertension among health checkup beneficiaries in Erode district, Tamilnadu

The study was conducted to find out the prevalence of obesity, prediabetes (Impaired fasting glucose-IFG), diabetes mellitus (DM), prehypertension (PreHTN) and hypertension(HTN) among health checkup beneficiaries who att...

Download PDF file
  • EP ID EP614743
  • DOI -
  • Views 149
  • Downloads 0

How To Cite

Ashish Sehgal (2018). SGLT-2 inhibitors and the metabolic fulcrum. Journal of the Indian Medical Association, 116(8), 51-53. https://europub.co.uk/articles/-A-614743